Psychopharmacology - Articles - Page 2

Fact Sheet

Deprescribing Medications in Older Adults

August 2, 2025

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Most older adults take more than five medications, making polypharmacy a significant issue in this population.

Fact Sheet

Important Drug-Drug Interactions in Older Adults

August 2, 2025

Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Older adults are particularly vulnerable to adverse drug reactions due to polypharmacy, medical comorbidities, and age-related changes in drug metabolism.

Fact Sheet

Managing Medication Side Effects in Older Adults

August 2, 2025

Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Older adults are particularly vulnerable to adverse drug reactions due to polypharmacy, medical comorbidities, and age-related changes in drug metabolism.

Clinical Guidance

Basics of Psychopharmacology in Older Adults

August 2, 2025

Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Psychopharmacology in older adults is uniquely complicated by age-related changes in drug metabolism, increased sensitivity to side effects, and the frequent presence of comorbid medical conditions.

Fact Sheet

Insomnia in Older Adults: Medication Treatment

August 2, 2025

Rehan Aziz, MD

Dr. Aziz has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Insomnia presents unique treatment challenges in older adults due to the potential for adverse drug reactions.

Research Update

Silexan for Depression?

August 1, 2025

Jennifer O'Hare, DNP, PMHNP-BC

Jennifer O’Hare, DNP, PMHNP-BC. Dr. O’Hare has no financial relationships with companies related to this material.

A trial compares the lavender oil extract Silexan to sertraline in mild to moderate depression.

Clinical Update

Substance Use Disorder Treatment: Medication or Psychotherapy?

July 1, 2025

Noah Capurso, MD, MHS

Noah Capurso, MD, MHS. Assistant Medical Director, Addiction Services Division, Connecticut Valley Hospital; Associate Clinical Professor of Psychiatry, Yale University; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Capurso has no financial relationships with companies related to this material.

Psychotherapy and medication management are the two cornerstones of addiction treatment, but they are not equally effective across different substance use disorders. This article reviews evidence from both therapeutic approaches and introduces the concept of a treatment spectrum, with medication on one end and therapy on the other. This spectrum can be a useful framework when discussing treatment options with patients and in treatment planning.

Psychopharm Secrets: Coming Off Meds

June 23, 2025

Chris Aiken, MD and Kellie Newsome, PMHNP

There’s a hidden placebo response to watch for when patients stop meds on their own.

Psychopharm Secrets: Starting Meds

June 16, 2025

Chris Aiken, MD and Kellie Newsome, PMHNP

We look at a hidden placebo effect that can confuse the picture when starting a medication.

Psychopharm Secrets: Side Effects

January 13, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.